Defining and Diagnosing Involuntary Emotional Expression Disorder

  title={Defining and Diagnosing Involuntary Emotional Expression Disorder},
  author={Jeffrey L. Cummings and David B. Arciniegas and Benjamin Rix Brooks and Robert M. Herndon and Edward C. Lauterbach and Erik P. Pioro and Robert G. Robinson and Douglas W. Scharre and R. Schiffer and Daniel Weintraub},
  journal={CNS Spectrums},
  pages={1 - 11}
Abstract Uncontrollable episodes of emotional expression occur in a variety of neurological conditions. This emotional disinhibition syndrome is characterized by episodes of crying or laughing that are unrelated to or out of proportion to the eliciting stimulus. This syndrome is common among patients with amyotrophic lateral sclerosis, multiple sclerosis, stroke, and traumatic brain injury and a variety of terms and definitions have been used to describe it. The confusing nomenclature has been… 

History and Prevalence of Involuntary Emotional Expression Disorder

It is hoped that better defined terminology forIEED may help in the future diagnosis of this debilitating condition, the establishment of accurate prevalence rates for IEED in the varying underlying conditions, and also in removing blame and stigma from sufferers by providing reassurance about the nature of their condition.

Involuntary Emotional Expression Disorder: Definition, Diagnosis, and Measurement Scales

Several assessment scales have been validated for use in IEED, in order to evaluate the baseline severity and to track the course of the disorder and response to treatment.

Frequency and correlates of involuntary emotional expression disorder in Parkinson's disease.

The lack of an association between IEED and depression suggests that, in spite of some symptom overlap, the two disorders are distinct neuropsychiatric syndromes in Parkinson's disease.

Pathophysiology of Involuntary Emotional Expression Disorder

Pharmacologic interventions targeting the neurochemical modulators of the emotional expression systems may afford opportunities for symptom control among persons affected by involuntary emotional expression disorder.

Involuntary emotional expression disorder in Alzheimer's disease - psychopharmacotherapy aspects.

United States Food and Drug Administration (FDA) has accepted for filing and review its New Drug Application (NDA) for Zenvia (dextromethorphan hydrobromide and quinidine sulfate capsules) for the treatment of IEED.

Pathological laughter and crying in neurological disorders: recognition and treatment

There is now good-quality evidence for a combination of dextromethorphan and quinidine, with weaker evidence for tricyclic and selective serotonin reuptake inhibitor antidepressants.

It's nothing to laugh about: understanding disorders of emotional expression.

  • Caren McHenry Martin
  • Psychology, Medicine
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists
  • 2007
Treatment options, including antidepressants, levodopa, and dextromethorphan/quinidine, may show promise in ameliorating symptoms for patients plagued with disorders of emotional expression.

Disturbances in the Voluntary Control of Emotional Expression After Stroke

It seems that PSEI is more often observed in the subacute stage than in the acute or chronic stage, however, there are patients who show abnormal emotional display before the onset of other major neurologic dysfunction (fou rire prodromique).

Pseudobulbar Affect Presenting as Aggressive Behavior

A 48-year-old man who presented with frequent episodes of sudden, frequent, uncontrollable laughing two years after his recurrent stroke is described and treated with dextromethorphan-quinidine, escitalopram, and divalproex, resulting in significant improvement in his mood and aggressive behavior.



Acute pathological laughter

A 16‐year‐old woman presenting with acute pathological laughter in the context of CNS demyelinating disease is reported on, providing further insights into the pathways of emotional control.

Pathological Laughing and Crying

Clinicians should remain vigilant for attacks of involuntary, irresistible laughing or crying, and offer effective treatments, such as antidepressants, where indicated, when indicated.

Regulation of Affect.

  • Green
  • Psychology, Medicine
    Seminars in clinical neuropsychiatry
  • 1998
The neurobiological bases of pathological crying are discussed, and the multiplicity of pathological entities and lesion locations that can produce this pathological affect are highlighted.

Review of pseudobulbar affect including a novel and potential therapy.

  • R. SchifferL. Pope
  • Psychology, Medicine
    The Journal of neuropsychiatry and clinical neurosciences
  • 2005
Evidence suggests that treatment with a fixed combination of dextromethorphan and the cytochrome P450 2D6 enzyme inhibitor, quinidine, can improve PBA.

The neuropsychiatry of pathologic affect: an approach to evaluation and treatment.

A framework for the description, evaluation, and treatment of affective dysregulation is described, along with several specific methods that appear to be useful in the evaluation of patients with affective lability.

Pathological laughing and crying following traumatic brain injury.

Examination of the prevalence and clinical correlates of pathological laughing and crying using the Pathological Laughter and Crying Scale revealed that prefrontal regulation of limbic circuits may be involved in the pathophysiology of this disturbed emotional expression.


Sixteen of 199 cases of disseminated sclerosis which have been the subject of detailed study were admitted to psychiatric hospitals sometime during the course of their illness, and all patterns of maladjustment have been seen.

Pathological Laughter: A Review of the Literature

  • D. Black
  • Psychology, Biology
    The Journal of nervous and mental disease
  • 1982
Normal laughter is a unique human behavior with characteristic facial and respiratory patterns elicited by a variety of stimulus conditions, but pathological laughter occurs when laughter is inappropriate, unrestrained, uncontrollable, or dissociated from any stimulus.

Treatment of pathological crying with citalopram.

This is the first report on the successful administration of citalopram for treating pathological crying in Parkinson's disease, and set of response was very rapid in all cases.

Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients

Results were observed if patients were classified as PLC or non-PLC according to CNS-LS score]-17, suggesting that the CNS- LS is a valid measure for the assessment of PLC in MS patients and could be a useful instrument for clinical and research purposes.